S100A10 and brain neoplasm: Importantly, S100A10 expression was highly up-regulated in GB clinical samples as compared to non-neoplastic brain tumor (Figure 8A), and higher expression of S100A10 was observed in both GB hypoxic core region and invasive margin compared to normal brain tissue (Figure 8B).